Legend Biotech Corp Stock Analysis

Legend Stock Analysis Notes

About 51.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.92. Legend Biotech Corp had not issued any dividends in recent years. Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation. Legend Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1071 people. To find out more about Legend Biotech Corp contact Ying Huang at 732 317 5050 or learn more at https://www.legendbiotech.com.

Legend Biotech Corp Investment Alerts

Legend Biotech Corp Upcoming and Recent Events

Legend Largest EPS Surprises

View All Earnings Estimates

Legend Biotech Environmental, Social, and Governance (ESG) Scores

Legend Stock Institutional Investors

Note, although Legend Biotech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Legend Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.29 B.

Legend Profitablity

The company has Profit Margin (PM) of (0.67) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.44) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.44.

Management Efficiency

Legend Biotech Corp has return on total asset (ROA) of (0.1228) % which means that it has lost $0.1228 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2835) %, meaning that it created substantial loss on money invested by shareholders. Legend Biotech's management efficiency ratios could be used to measure how well Legend Biotech manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of November 2024, Return On Tangible Assets is likely to drop to -0.3. In addition to that, Return On Capital Employed is likely to drop to -0.28. At this time, Legend Biotech's Net Tangible Assets are very stable compared to the past year. As of the 22nd of November 2024, Non Current Assets Total is likely to grow to about 368.4 M, while Total Assets are likely to drop about 938.8 M.

Technical Drivers

As of the 22nd of November, Legend Biotech secures the Mean Deviation of 2.26, standard deviation of 3.13, and Risk Adjusted Performance of (0.11). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Legend Biotech Corp, as well as the relationship between them.

Legend Biotech Corp Price Movement Analysis

Legend Biotech Outstanding Bonds

Legend Biotech Predictive Daily Indicators

Legend Biotech Corporate Filings

Legend Biotech Forecast Models

Legend Biotech's time-series forecasting models are one of many Legend Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Legend Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Legend Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Legend shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Legend Biotech. By using and applying Legend Stock analysis, traders can create a robust methodology for identifying Legend entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Legend analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Legend analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Legend Biotech Corp stock analysis indicators help investors evaluate how Legend Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Legend Biotech shares will generate the highest return on investment. By understating and applying Legend Biotech stock analysis, traders can identify Legend Biotech position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend Biotech Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.